Qube Research & Technologies LTD Astrazeneca PLC Call Options Transaction History
Qube Research & Technologies LTD
- $82.3 Billion
- Q1 2025
Call Options
3 transactions
Others Institutions Holding AZN
# of Institutions
1,422Shares Held
505MCall Options Held
9.82MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$4.37 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$3.11 Billion2.53% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.73 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.44 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.4 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $237B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...